LITTLE KNOWN FACTS ABOUT NUC-7738.

Dosages ought to be individualized based on the proposed aim of therapy as well as the client’s reaction.Rhabdomyolysis with renal dysfunction secondary to myoglobinuria have already been documented with other HMG-CoA reductase inhibitors. This has not been noted with cerivastatin sodium thus far. Cerivastatin therapy should be discontinued if ma